Cannabis Bioscience International Holdings (CBIH) Other Working Capital Changes (2023 - 2025)
Cannabis Bioscience International Holdings' (CBIH) quarterly Other Working Capital Changes came in at -$14111.0 in Q4 2025, down 205.76% year-on-year from $13342.0 in Q4 2024, and down 217.59% quarter-over-quarter from $12000.0 in Q3 2025.
Cannabis Bioscience International Holdings (CBIH) Other Working Capital Changes (2023 - 2025) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Other Working Capital Changes across 3 years of filings, most recently posting -$14111.0 for Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at -$14111.0, down 205.76% year-over-year; the trailing twelve-month figure through Feb 2026 was -$10143.0 (up 26.74% YoY), and the FY2025 annual result was -$21877.0, up 23.62% from the prior year.
- Other Working Capital Changes came in at -$14111.0 for Q4 2025 at Cannabis Bioscience International Holdings, down from $12000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $12000.0 in Q3 2025 to a low of -$43423.0 in Q2 2023.
- The 3-year median for Other Working Capital Changes is -$8032.0 (2025), against an average of -$10672.4.
- Peak annual rise in Other Working Capital Changes reached 363.27% in 2025, while the deepest fall reached 205.76% in 2025.
- Cannabis Bioscience International Holdings' Other Working Capital Changes stood at -$20308.0 in 2023, then soared by 77.27% to -$4615.0 in 2024, then plunged by 205.76% to -$14111.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$14111.0 (Q4 2025), $12000.0 (Q3 2025), and -$8032.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -14,111.00 |
| Nov 30, 2025 | -14,111.00 |
| Aug 31, 2025 | 12,000.00 |
| Aug 31, 2025 | 12,000.00 |
| May 31, 2025 | -8,032.00 |
| May 31, 2025 | -8,032.00 |
| Feb 28, 2025 | -4,672.00 |
| Feb 28, 2025 | -4,672.00 |
| Nov 30, 2024 | -4,615.00 |
| Nov 30, 2024 | -4,615.00 |
| Aug 31, 2024 | -4,558.00 |
| Aug 31, 2024 | -4,558.00 |
| Nov 30, 2023 | -20,308.00 |
| Nov 30, 2023 | -20,308.00 |
| Aug 31, 2023 | -8,333.00 |
| Aug 31, 2023 | -8,333.00 |
| May 31, 2023 | -43,423.00 |
| May 31, 2023 | -43,423.00 |